Mangoceuticals (MGRX) Gross Profit (2023 - 2026)

Mangoceuticals has disclosed Gross Profit across 4 years of filings, most recently posting $29001.0 for Q1 2026.

• Gross Profit for Q1 2026 came in at $29001.0, down 53.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $217323.0 (down 26.24% YoY), and the FY2025 annual result was $250386.0, down 34.1% from the prior year.
• Gross Profit came in at $29001.0 for Q1 2026 at Mangoceuticals, down from $47475.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $147398.0 in Q1 2024 to a low of $29001.0 in Q1 2026.
• The 4-year median for Gross Profit is $80103.0 (2024), against an average of $83911.7.
• Across the five-year window, Gross Profit jumped 157.69% in 2024 and tumbled 57.89% in 2025, its largest moves.
• Mangoceuticals' Gross Profit stood at $142583.0 in 2023, then tumbled by 43.82% to $80103.0 in 2024, then slumped by 40.73% to $47475.0 in 2025, then sank by 38.91% to $29001.0 in 2026.
• The last three Gross Profit figures came in at $29001.0 (Q1 2026), $47475.0 (Q4 2025), and $50899.0 (Q3 2025), per Business Quant data.